BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 28 2022 - 6:45AM
Mainz, Germany, December 28, 2022 (GLOBE NEWSWIRE)
– BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced
today that CEO and Co-founder Prof. Ugur Sahin, M.D., will present
a corporate overview and update at the 41st Annual J.P. Morgan
Healthcare Conference on Tuesday, January 10, 2023, at 9:45 am PST
/ 12:45 pm ET.
A live webcast of the presentation will be
available via the “Events & Presentations” page in the Investor
Relations section on the Company’s website at
https://biontech.com/. The replay of the webcast will be archived
on the Company’s website for 30 days following the conference.
About BioNTech Biopharmaceutical New
Technologies is a next generation immunotherapy company pioneering
novel therapies for cancer and other serious diseases. The Company
exploits a wide array of computational discovery and therapeutic
drug platforms for the rapid development of novel
biopharmaceuticals. Its broad portfolio of oncology product
candidates includes individualized and off-the-shelf mRNA-based
therapies, innovative chimeric antigen receptor T cells, bispecific
immune checkpoint modulators, targeted cancer antibodies and small
molecules. Based on its deep expertise in mRNA vaccine development
and in-house manufacturing capabilities, BioNTech and its
collaborators are developing multiple mRNA vaccine candidates for a
range of infectious diseases alongside its diverse oncology
pipeline. BioNTech has established a broad set of relationships
with multiple global pharmaceutical collaborators, including
Genmab, Sanofi, Genentech, a member of the Roche Group, Regeneron,
Genevant, Fosun Pharma, and Pfizer.
For more information, please visit
www.BioNTech.com.
CONTACT
Investor RelationsSylke Maas, Ph.D.+49
(0)6131 9084 1074Investors@biontech.de
Media RelationsJasmina Alatovic+49
(0)6131 9084 1513Media@biontech.de
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Apr 2023 to Apr 2024